1001387-68-3

Upstream product

• 635-21-2 5-chloroanthranilic acid 
• 152911-43-8 (2-amino-5-chlorophenyl)(2,3-dimethoxyphenyl)methanone 

Downstream Products

• 1001387-69-4 {5-Chloro-2-[3-(dimethoxymethyl)-5-isopropylisoxazol-4-yl]phenyl}(2,3-dimethoxyphenyl)-methanone 
• 1314186-14-5 C₃₀H₃₃ClN₂O₇ 
• 1314186-12-3 C₃₁H₃₅ClN₂O₇ 
• 1314186-10-1 C₂₈H₃₁ClN₂O₆ 
• 1001387-56-9 [(4S,6R)-8-chloro-6-(2,3-dimethoxyphenyl)-1-isopropyl-4H,6H-[2]benzoxepino[4,5-c]isoxazol-4-yl]acetic acid 
• 1001387-55-8 [(4R,6S)-8-chloro-6-(2,3-dimethoxyphenyl)-1-isopropyl-4H,6H-[2]benzoxepino[4,5-c]isoxazol-4-yl]acetic acid 
• 1314186-06-5 ethyl [8-chloro-6-(2,3-dimethoxyphenyl)-1-isopropyl-4H,6H-[2]benzoxepino[4,5-c]isoxazol-4-yl]acetate 
• 1314185-97-1 C₂₆H₂₆ClNO₆ 

Relevant academic research and scientific papers

Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors

Novel squalene synthase inhibitors are disclosed. The design, synthesis, SAR and pharmacological profile of the compounds are discussed.

Substituted benzoxepino-isoxazoles and use thereof

The present application relates to novel substituted benzoxepinoisoxazole derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxi